SCHEMBL27612366

SCHEMBL27612366

CC(Cl)(Nc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.47
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C19 P33261 2/20 0.46
MAPT P10636 2/20 0.46
PPARA Q07869 2/20 0.46
CYP2D6 P10635 1/20 0.46
NPC1 O15118 4/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
RAB9A P51151 3/20 0.45
PDK1 Q15118 1/20 0.45
PDK2 Q15119 1/20 0.45
PDK3 Q15120 1/20 0.45
PDK4 Q16654 1/20 0.45
ALDH1A1 P00352 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
TSHR P16473 2/20 0.43
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3374091 0.82 POLB (0.58) POLBMEN1KMT2ACYP1A2CYP3A4
SCHEMBL19707851 0.74 KMT2A (0.45) POLBMEN1KMT2ACYP1A2CYP3A4
SCHEMBL4488511 0.74 MIF (0.50) POLBMEN1KMT2ACYP1A2CYP3A4
SCHEMBL7227231 0.72 POLB (0.53) POLBMEN1KMT2AMAPTNPC1
SCHEMBL19707314 0.72 POLB (0.54) POLBMEN1KMT2ACYP1A2CYP3A4
SCHEMBL11249289 0.72 PDK1 (0.60) POLBMEN1KMT2ACYP1A2CYP3A4
SCHEMBL7424794 0.72 PDK1 (0.60) POLBMEN1KMT2ACYP1A2CYP3A4
SCHEMBL4742572 0.69 MEN1 (0.55) POLBMEN1KMT2ACYP1A2CYP3A4
SCHEMBL11461831 0.69 SMN1; SMN2 (0.68) MEN1KMT2AMAPTNPC1SMN1; SMN2
SCHEMBL23137177 0.68 PPARG (0.50) POLBMEN1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1678321-A Methods of treating or preventing autoimmune diseases with 2, 4-pyrimidinediamine compounds RIGEL PHARMACEUTICALS INC (US) 2005-10-05 CN disclosed